Multi‐Omic Analysis Reveals the Impact of Bortezomib in Hyperleukocytic Acute Myeloid Leukemia

ABSTRACT Background Hyperleukocytic acute myeloid leukemia (HL‐AML) is associated with early complications and high mortality rates, highlighting the urgent need for more effective therapeutic strategies. Methods This study conducted label‐free proteomic analysis on serum from HL‐AML and non‐HL AML...

Full description

Bibliographic Details

Published in:	Cancer Medicine
Main Authors:	Jinxian Wu, Xinqi Li, Bei Xiong, Wanyue Yin, Ruihang Li, Guopeng Chen, Linlu Ma, Xiqin Tong, Xiaoyan Liu, Fuling Zhou
Format:	Article
Language:	English
Published:	Wiley 2024-11-01
Subjects:	bortezomib hyperleukocytic acute myeloid leukemia NF‐kappa B pathway proteomics
Online Access:	https://doi.org/10.1002/cam4.70438